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 Fluorescence in situ hybridisation analysis of chromosomal
aberrations in gastric tissue: the potential involvement of
Helicobacter pylori
L Williams*,1, GJS Jenkins2, SH Doak2, P Fowler3, EM Parry3, TH Brown4, AP Griffiths5, JG Williams1 and
JM Parry3
1Neath Port Talbot Hospital, Baglan, UK; 2Swansea Clinical School, University of Wales, Swansea, UK; 3School of Biological Sciences, University of Wales,
Swansea, UK; 4Department of Surgery, Morriston Hospital, Swansea, UK; 5Department of Pathology, Morriston Hospital, Swansea, UK
In this series of experiments, a novel protocol was developed whereby gastric cells were collected using endoscopic cytology brush
techniques, and prepared, such that interphase fluorescence in situ hybridization (FISH) could be performed. In total, 80 distinct
histological samples from 37 patients were studied using four chromosome probes (over 32 000 cells analysed). Studies have
previously identified abnormalities of these four chromosomes in upper GI tumours. Using premalignant tissues, we aimed to
determine how early in Correa’s pathway to gastric cancer these chromosome abnormalities occurred. Aneuploidy of chromosomes
4, 8, 20 and 17(p53) was detected in histologically normal gastric mucosa, as well as in gastritis, intestinal metaplasia, dysplasia and
cancer samples. The levels of aneuploidy increased as disease severity increased. Amplification of chromosome 4 and chromosome
20, and deletion of chromosome 17(p53) were the more common findings. Hence, a role for these abnormalities may exist in the
initiation of, and the progression to, gastric cancer. Helicobactor pylori infection was determined in premalignant tissue using
histological analysis and PCR technology. Detection rates were comparable. PCR was used to subtype H. pylori for CagA status. The
amplification of chromosome 4 in gastric tissue was significantly more prevalent in H. pylori-positive patients (n¼ 7) compared to
H. pylori-negative patients (n¼ 11), possibly reflecting a role for chromosome 4 amplification in H. pylori-induced gastric cancer. The
more virulent CagA strain of H. pylori was associated with increased disease pathology and chromosomal abnormalities, although
numbers were small (CagAþ n¼ 3, CagA n¼ 4). Finally, in vitro work demonstrated that the aneuploidy induced in a human cell
line after exposure to the reactive oxygen species (ROS) hydrogen peroxide was similar to that already shown in the gastric cancer
pathway, and may further strengthen the hypothesis that H. pylori causes gastric cancer progression via an ROS-mediated mechanism.
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Gastric cancer is the second most deadly cancer worldwide,
accounting for 649 000 deaths each year and 876 000 incident
cases in the world each year (Parkin et al, 2001). In the UK, it is the
fifth most frequent cancer in men and the ninth in women (www.
cancerresearchuk.org/cancerstats/).
Gastric cancer is often diagnosed at an advanced stage when
symptoms such as weight loss, abdominal pain, vomiting and
gastrointestinal bleeding finally alert patients to seek medical
advice. Treatment regimens, such as surgery, chemotherapy and
radiotherapy, are therefore limited by the extent of advanced local
disease and metastatic spread. In fact, only 55– 65% of gastric
cancers are surgically resectable at diagnosis (Keighley, 2003).
Hence, the prognosis of gastric cancer is poor, helping to make
gastric cancer a leading cause of cancer death worldwide (Parkin
et al, 2001). The early detection of gastric cancer (or a pre-
malignant form with a high risk of progression) could improve the
current poor survival rates. Correa (1988) has outlined a multistep
pathway to gastric adenocarcinoma, involving precancerous
stages, gastritis and intestinal metaplasia, and hence, it may be
that finding molecular markers, which are associated with these
early histological changes, could improve prognosis.
It has been well established that chromosome abnormalities are
implicated in the initiation and progression of many forms of
cancer, including gastric cancer (Lengauer et al, 1997; Nardone
et al, 1999). Aneuploidy (abnormal chromosome numbers) of
varying degrees has previously been documented in all stages of
gastric cancer (Beuzen et al, 2000). In an effort to assess whether
early chromosome abnormalities might represent suitable diag-
nostic molecular markers of gastric cancer, we undertook a
cytogenetic evaluation of all histological stages of gastric cancer.
Specifically, we used previously published cytogenetic data from
upper GI tract cancers produced by us, and others, to see how early
in premalignant gastric cancer, these events occurred and if they
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could be linked to infection with Helicobactor pylori. After an
extensive literature search for chromosome abnormalities in upper
GI tract cancer, we chose four of the most common or most
interesting chromosomes for study (we limited the study to four
chromosomes due to time constraints). We chose here to study
copy number abnormalities of chromosomes 4, 8, 20 and the p53
locus (chromosome 17) over the full histological range of gastric
cancer. Aneuploidy involving chromosome 20 and 8 has been
shown in several studies of gastric cancer tissue (Kokkola et al,
1998; Beuzen et al, 2000; Kitayama et al, 2000; Koo et al, 2000;
Okada et al, 2000; Wu et al, 2001). Chromosome 4 aneuploidy has
also been implicated in another upper GI malignancy, oesophageal,
by our group (Croft et al, 2002; Doak et al, 2003). P53 is the most
frequently mutated gene in human cancer (Levine et al, 1991;
Tamura et al, 1991; Vogelstein and Kinzer, 1992; Sipponen et al,
1998) and is commonly found to be abnormal in 30– 58% of
intestinal and diffuse gastric tumours (Grady, 2001). Hence, here
we assessed whether copy number changes of these four chromo-
somes occurred in gastritis or intestinal metaplasia, as well as
dysplasia and adenocarcinoma.
A number of agents are thought to play a role in the aetiology of
gastric cancer and include the infectious agent H. pylori. In 1994,
the International Agency for Research on Cancer (IARC) declared
H. pylori a class one human carcinogen, capable of inducing
changes leading to gastric cancer (IARC, 1994). Helicobator pylori
is linked causally to gastric cancer and we know that the
production of reactive oxygen species (ROS) is one way that the
bacterium exerts its effect on gastric cells (Correa, 1988; Asaka
et al, 1997; Chan et al, 1999; Obst et al, 2000). Indeed, O’Connor
and Sebastian (2003) suggested that H. pylori infection may
account for 60% of all gastric cancers worldwide. There is now a
large body of evidence linking H. pylori to gastric cancer with
epidemiological studies showing a 3 –12-fold increased risk of
gastric cancer in those people infected with H. pylori (Cover and
Blaser, 1995). Helicobactor pylori strains with the CagA patho-
genicity island are known to be more virulent, producing more
severe pathological infection in humans (Blaser, 1998). CagAþ
strains are highly immunogenic strains of H. pylori and are
associated with increased cytokine expression (Crabtree et al,
1995), inflammatory cell infiltrate and release of ROS adjacent to
gastric mucosa (Fiocca et al, 1994; Sipponen et al, 1998). The
oxidative DNA damage induced by ROS is an important
mechanism in carcinogenesis. It has been implicated in up to
50% of all human cancers (Beckman and Ames, 1997) and
importantly, has been considered a potential causative agent in
gastric cancer (Correa and Shiao, 1994; Stadtlander and Waterbor,
1999). Therefore, we also examined here the effect of ROS exposure
on chromosome stability in vitro. We exposed human cells to
subtoxic doses of hydrogen peroxide (H2O2), and used the
micronucleus assay and fluorescence in situ hybridization FISH
to assess chromosome damage. The micronucleus assay is
routinely used to study chromosome damage (Fenech et al,
1999) and can detect chromosome fragmentation (induction of
micronuclei) as well as whole chromosome loss (using kinetochore
staining).
METHODS
Patient enrolment into the study
Patients attending Neath Port Talbot Hospital for upper GI
endoscopy were invited to participate in this study. The hospital is
situated in a mixed rural and urban area of West Wales, and serves
a socially deprived population of approximately 140 000. Ethical
Approval was obtained from the local ethics committee and
samples were only taken from consenting adults. Exclusions to the
study were made when consent could not be adequately given,
when the patient was taking proton pump inhibitors or
nonsteroidal anti-inflammatory drugs, had undertaken recent H.
pylori eradication or had a history of previous upper GI surgery.
Information was collected on sex, age, ethnicity, family history,
diet, smoking, alcohol and drug intake, prior to the endoscopy.
Endoscopic cytology brushings
Cytology brushes (Diagmed Ltd., Thirsk, UK) were used to collect
cells from the gastric and oesophageal mucosa. This methodology
has previously been described by us, for use in analysing
oesophageal samples (Doak et al, 2003). The advantages of using
cytology brushes to collect cells for cytogenetic studies include the
broader area from which the cells are collected and the fact that
primarily only epithelial cells are sampled. Gastric brushes were
taken at the same site as the gastric biopsies used for histological
diagnosis and PCR detection of H. pylori. Gastric brushes were
targeted at macroscopically abnormal stomach when present,
otherwise antral brushes were taken. Oesophageal brushes were
taken from macroscopically normal distal oesophagus for com-
parison. The area of stomach to be sampled was washed with 20 ml
sterile water prior to brushing. Brushes were also taken prior to
biopsy, to minimise bleeding. No patient reported any immediate
complications following this procedure.
Optimisation of the collection of gastric cells for interphase
FISH was extensively carried out, the optimal protocol is described
here. Brushes were stored in 10 ml of 90% methanol, on ice, in the
Endoscopy Unit prior to transportation to the laboratory.
Vigorous shaking of the brushes to dislodge the cells from the
bristles immediately after storage in methanol was found to
improve cell yield. These brushes were stored successfully for up to
a week.
Cytology brushes from surgical resections of gastric cancer
Surgical resection specimens from 10 patients undergoing
gastrectomy for gastric cancer at Morriston Hospital, Swansea
were identified by a Consultant Pathologist (APG). Multiple
brushings from the surgical resection specimens were taken,
together with biopsies at the same sites, hence allowing histological
diagnosis. The cytology brushes were stored in 90% methanol
within 30 min of resection.
Interphase cell preparations
The cell suspensions were washed three times by centrifugation/
resuspension in ETN buffer (0.1 M EDTA, 10 mM Tris-HCl pH7,
20 mM NaCl) (Doak et al, 2003). The resultant cell pellet was
resuspended in 0.5 ml ETN buffer and a cytodot was produced on a
glass slide using a Cytospin 4 (ThermoShandon, Cheshire, UK).
Larger pellets were resuspended in 1 ml ETN buffer. The cytodot
was examined with a light microscope, and cell suspensions were
diluted accordingly to ensure that an adequate number of cells,
evenly spaced apart, were present for interphase FISH. Oesopha-
geal cells were easily visualised, but the gastric cells frequently had
no clear cytoplasm/cell membrane, appearing to be partially
digested. This improved when the brushes were stored in 90%
methanol, and not ETN, giving a better yield of cells. Cell
preparations on slides were fixed in 90% methanol at 201C for
10 min and left to air dry. An average of 2– 5 slides were produced
per sample. Interphase cell preparations were incubated at 371C
for 10 min and then treated with 300 ml ml1 HCl pepsin, pH 2.7–3
(Sigma, Dorset, UK) at 371C, to remove cytoplasmic proteins,
hence improving probe penetration. Oesophageal cells were
treated for 7 min as described by Doak et al, 2003, but over this
period of time overdigestion of gastric cells resulted in loss of
nuclei. Again, this suggested that partial gastric cell digestion had
already occurred, therefore the pepsin digestion time was reduced
to 5 min and the yield improved. Slides were washed in PBS
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(5 min) and PBS/MgCl2 (5 min) at room temperature to arrest the
enzymatic action of pepsin. They were then dehydrated in
increasing concentrations of ethanol prior to FISH.
Interphase FISH
Centromeric enumeration probes (CEN) for chromosomes 4, 8 and
20, and a locus-specific identifier probe (LSI) for p53 (all Vysis,
Surrey, UK) were used. Two probes were used simultaneously
(20þ 4, p53þ 8). Fluorescence in situ hybridisation was performed
according to slightly modified manufacturer’s instructions. In
total, 5 ml of probe mixture was added to each cytodot (3.5 ml
hybridisation buffer, 0.5 ml of each probe and 1 ml of water). The
sample and probe were codenatured on a 751C hotplate for 2 min
and incubated in the dark at 371C for 30 min (CEN) or 16 h (LSI).
Slides were washed for 2 min at 731C with 0.4 SSC/0.3% Nonidet
P-40, and for 30 s at room temperature in 2 SSC/0.1% Nonidet
P-40, and allowed to air dry in the dark. To counter stain the
nuclei, 10 ml Dapi (Vysis, Surrey, UK) was added to each slide.
Signal visualisation and scoring
An Olympus BX50 microscope and Powergene 4.3 software
(Applied Imaging, Newcastle Upon Tyne, UK) were used to score
each slide. Slides with o100 cells were excluded and an average of
223 cells per slide was scored (range 100–452). In total,
approximately 32 000 cells were scored for chromosome abnorma-
lities (223 cells per slide, two slides per brush, two brushes per
patient (up to eight brushes per surgical patient), 37 patients).
Nuclei were only included if they had at least one signal from each
probe to avoid inclusion of results where hybridisation was
inadequate. Nuclei that were smeared or overlapping were also
excluded.
Centromeric enumeration probes highlight the centromere of
the chromosome and were used to determine whole chromosome
changes, that is, aneuploidy. A loss of a CEN signal was assumed to
be a deletion of that chromosome, and more than two signals was
determined an amplification. The LSI probe for p53 was a marker
of that gene locus, and again a loss of a signal represented deletion,
whereas a gain represented amplification.
Slides were coded before scoring, with no knowledge of the
histological details of the tissue sample.
Statistical analysis of chromosomal abnormalities
Fishers exact test was used to compare the chromosomal changes
between the differing histological diagnoses, P-values o0.05 were
deemed to represent significant differences.
The reproducibility of this technique was assessed by perform-
ing FISH with the same probes on different slides from the same
gastric brush. No statistical differences in the levels of aneuploidy
were noted.
PCR determination of H. pylori
Antral biopsies were taken from patients at the time of endoscopy
and DNA was extracted using a Stratagene DNA extraction kit
(Stratagene, Cambridge, UK). A UV spectrophotometer (Beckman
DU 530) was used to quantitate the DNA extracted from
each biopsy and 200– 500 ng was used for subsequent PCR
analysis. Helicobactor pylori flagellin primers, designed by
ourselves (forward: AAACCAATCGCTGTGAAACC, reverse: ACGG
AAGGCTTTCTCTCACA) were used to generate a 94 base pair
fragment of the flagellin gene. The CagA primers were synthesised
according to Lage et al, 1995. Both the flagellin PCR and the CagA
PCR were optimised internally such that single band PCR products
were obtained. The PCR reaction comprised 1.5 mM MgCl2, 400 mM
dNTPs, 200–500 ng DNA, 2.5 U of Taq polymerase (Promega,
Southampton UK) and Taq-specific 10 buffer. The PCR was
performed in a DNA engine (MJ research, Watertown, MA, USA)
and the thermal profile was as follows: 941C for 2 min and 30 cycles
of 941C for 30 s, 601C for 20 s and 721C for 20 s. PCR products
were visualised post-PCR by PAGE using 5% polyacrylamide. The
gels were run in Protean III electrophoresis systems (BioRad,
HemelHempstead, UK) and poststained with silver.
In vitro ROS study
Cells from the human cell line, AHH1 (Genetest Corporation), used
in routine chromosome damage assays, were prepared in tissue
culture and dosed with 0, 50, 100 mM H2O2 (Sigma Aldrich) for
30 min, followed by 24 h recovery. Hydrogen peroxide was chosen
as the model ROS due to its ease of administration and as it is
thought to represent a diffusible form of ROS. This dose was
chosen as it was subtoxic and has previously been shown to cause
DNA/chromosomal damage (Rueff et al, 1993; Perwez Hussain
et al, 1994; Duthie et al, 1997; Fenech et al, 1999; Umegaki and
Fenech, 2000; Jenkins et al, 2001). Initially, the micronucleus assay
was performed to determine if chromosome damage was induced
following standard protocols (Fenech and Morley, 1985; Fenech
et al, 1999). The micronuclei were subsequently stained with a
kinetochore label to assess if whole chromosomes were present
within them. Secondly, FISH analysis was performed to specifically
look at copy numbers of chromosomes 4, 8, 20 and 17(p53), post
H2O2 exposure.
RESULTS
A total of 27 patients met the inclusion criteria and were enrolled
at the Endoscopy department at Neath Port Talbot Hospital. Three
additional premalignant patient samples were obtained from
brushes taken at the Pathology Department in Morriston Hospital
from surgical resections. Hence, the total number of patient’s
samples with premalignant gastric disease considered in this part
of the study was 30, but four endoscopic patients were not
included in final analysis because of insufficient cells/inadequate
histology. Samples from 10 patients undergoing surgical resections
of tumours were also studied. These surgical samples often
supplied adjacent premalignant tissue as well as adenocarcinoma
material. Details of age/sex of patients, site of lesion and
histological diagnosis are illustrated in Table 1. All the stages of
Correa’s multistep pathway to cancer (normal gastric tissue,
gastritis, intestinal metaplasia, dysplasia) could be demonstrated
in some of the individual surgical resections. Helicobactor pylori
infection was not identified in any late stage surgical sample as is
Table 1 Patient characteristics as subdivided by histological diagnosis
Number Mean age % Male % Smoking % Alcohol excess % Family history % H. pylori infection
Gastric normal 9 67 12.5 50 12.5 12.5 0
Gastritis 10 66 40 20 0 30 50
Intestinal metaplasia 4 69 50 25 50 12.5 16.6
Dysplasia (n¼ 1)/cancer (n¼ 9) 10 63 50 No information No information No information 0
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usual in gastric tissue that has become malignant (Graham, 2000;
You et al, 2000).
Aneuploidy was demonstrated at all stages of progression to
gastric cancer, with the abundance of aneuploid cells increasing
with disease severity. Also, the individual malignant gastric cells
contained multiple copy number changes compared to the early
premalignant tissue, in which single abnormalities tended to be
seen. Interestingly, the normal gastric tissue contained higher
levels of background chromosome abnormalities than the matched
oesophageal samples, presumably as a result of the harsher
conditions present in the stomach. The cumulative chromosome
abnormality data across the histological series is shown in Figure 1.
Amplification of chromosome 4, deletion of p53 and amplification
of chromosome 20 were the most significant events found in the
premalignant stages of gastric carcinogenesis. Figure 2 demon-
strates some of the types of aneuploidy detected using FISH.
Table 2 illustrates the rank order that individual amplifications
and deletions appeared in the premalignant and malignant stages.
As can be seen, amplification of chromosome 4, amplification of 20
and deletion/amplification of p53 are the most frequently noted
events.
One of the gastric tumours studied was located at the gastro-
oesophageal junction and as such had received preoperative
chemotherapy. The same type of aneuploidy was seen in this
tumour as in the distal cancers, but the frequency of abnormalities
shown were less, possibly reflecting the effect of chemotherapy.
Also, the gastric normal tissue in this patient was analysed
separately and when compared to the gastric normal tissue from
the other patients in this study, chromosomal abnormalities were
higher. This may possibly suggest induced aneuploidy by the
chemotherapy treatment, as has been shown in other studies (Acar
et al, 2001; Kamiguchi and Tateno, 2002; Silva et al, 2002; Frias
et al, 2003), but numbers are obviously too small to confirm this.
Furthermore, in several cases, multiple brushes were taken from
the same tumour to study intratumoural heterogeneity. There was
indeed heterogeneity in the aneuploidy present in different parts of
the same tumour.
Chromosomal abnormalities in H. pylori-positive samples
vs H. pylori-negative samples
The identification of H. pylori in the endoscopic cohort of patients
(i.e., gastritis and IM only) was determined using PCR as well as
histology in 18 patients. The use of PCR here can improve the
detection rates by 10% or so (Ishmail, 2004). In all, 39% of the 18
patients (seven out of 18) attending the endoscopy clinic were
H. pylori positive by PCR and histology. All patients with H. pylori
infection had abnormal gastric tissue. Figure 3 illustrates the
significant increases in levels of aneuploidy present in H. pylori-
positive patients (n¼ 7) as compared to H. pylori-negative
individuals (n¼ 11). CagA status was also determined within this
subset, with three out of seven infections possessing CagA. The
numbers of patients in each group here are too small to make firm
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p53
Oesophageal (n = 18)
Normal gastric
(n = 9)
Gastritis
(n = 10)
Chromosome
Intestinal
metaplasia
(n = 7)
Dysplasia
(n = 2)
Distal adenocarcinoma
(n = 8)
Figure 1 Overall aneuploidy (lossþ gain) during the histological
progression. All chromosome abnormalities become more prevalent
during cancer progression. Interestingly, man chromosome abnormalities
are more present in normal gastric tissue than normal oesophageal tissue.
Normal chromosome complement 
− two copies of 20 (red), 
two copies of 4 (green)
Deletion of chromosome 20
− one copy of 20 (red)
Amplification of chromosome 20
− three copies of 20 (red)
Amplification of chromosome 4
− four copies 4 (green)
− three copies 4 (green)
Figure 2 Examples of chromosomal abnormalities identified in gastric
epithelial cells.
Table 2 Fold increase in chromosomal abnormalities as disease severity worsens in gastric tissue
Chromosomal
abnormality
Increase in gastritis
cf. normal gastric
Increase in IM cf.
normal gastric
Increase in
dysplasia cf. normal
gastric
Increase in cancer
cf. normal gastric
4 gain  4.7  5.5  6.2  15.0
20 gain  2.9  7.9  16.4  20.0
P53 loss  2.2  2.9  4.4  6.0
8 loss  1.5  2.2  2.5  2.6
4 loss  1.4  2.0  l.6  2.3
8 gain  l.3  l.7  2.3  6.5
P53 gain  1.3  5.5  7.0  13.0
20 loss  l.2  l.3  0.7  l.8
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conclusions, but increased aneuploidy was present with the
CagAþ strains, notably involving chromosomes 4 and 8.
In vitro analysis of chromosomal abnormalities induced by
ROS
The in vitro study using the micronucleus assay to determine the
effects of ROS exposure on human cells demonstrated, as expected,
that chromosome damage increased with ROS dose. Kinetochore
staining confirmed that these micronuclei often contained whole
chromosomes. Hence, ROS exposure lead to the production of
aneuploidy. Fluorescence in situ hybridisation analysis further
illustrated that abnormalities of chromosomes 20, 8, 4 and 17(p53)
were induced by ROS exposure. Figure 4 summarises the FISH data
showing the statistically significant chromosome abnormalities
induced in the cell line by this particular ROS.
DISCUSSION
We show here that interphase FISH, in conjunction with brush
cytology, successfully allowed karyotype changes, in both pre-
malignant and malignant gastric tissue, to be monitored. This
approach has previously been developed to analyse aneuploidy in
oesophageal tissue (Doak et al, 2003). If an association between
aneuploidy in premalignant cells and gastric cancer risk were to be
established, this approach may be suitable as a surveillance tool.
The most important adaptation needed for extending the method
to gastric tissue involved accounting for intrinsic cell digestion by
gastric juice. Interestingly, we show here that background
aneuploidy levels in histologically normal gastric tissue were
elevated compared to normal oesophageal tissue. This is pre-
sumably due to the harsh environment endured by the gastric cells,
hence, the suggestion is that acid or bile, key agents in gastric
contents, may play a role in inducing aneuploidy in gastric tissue.
Bile and acid have previously been implicated as having a role in
the mechanism of upper GI cancer. Bile acids in particular have
been shown to cause DNA damage (Scates et al, 1995, 1996) and
chromosomal aberrations (D’Souza et al, 2003).
Gastric cancer presents late, and as such, treatment options are
limited and currently survival rates are poor. Improving the
outcome of cancers can often be achieved by identifying people at
a high risk of developing cancer (Hussain and Harris, 1998) and by
early cancer detection (Matturri et al, 1998). The latter has been
addressed in Japan, where the incidence of gastric cancer is one of
the highest worldwide, and screening programmes have been
developed to diagnose lesions early, improving the 5-year survival
rates to 95%. Unfortunately, only 10% of European gastric cancers
are detected early (Keighley, 2003). The identification of molecular
markers to determine early disease may be one approach whereby
survival rates could be improved. Identifying the actual mecha-
nisms that lead to the aneuploidy demonstrated in early gastric
carcinogenesis may even help to identify therapeutic agents
capable of halting the carcinogenic process at its earliest stages.
The detection of chromosomal instability, even in premalignant
stages, as found in this study, may help to explain the aggressive
nature of this disease. Furthermore, intratumoural heterogeneity
was also detected in a number of the tumours analysed. This
phenomenon has been recognised in other gastrointestinal
cancers, reflecting the general instability of the tumour, and the
development of de novo genetic abnormalities in individual cells.
Owonikoko et al (2002) demonstrated this phenomenon in
Barrett’s associated cancers, using a number of genetic markers,
whereas Lindforss et al (2000) has shown similar events in cancers
of the lower GI tract. If a tumour shows significant intratumoural
heterogeneity, then the likelihood is that at least one of the various
clones of cells present will survive chemotherapy and the cancer
will continue to grow.
There were no associations between the aneuploidy detected in
this study and the smoking history of patients, or sex, age or diet.
However, there was a strong association with the histological stage
of the gastric tissue, and aneuploidy events increased in frequency
as the tissue histology approached cancer. Gastric cancer is said to
be a predominantly male disease (Sipponen et al, 1998; Faraji
and Frank, 2002; Grady, 2001), however, in the premalignant
cohort studied, only 33% were male increasing to 50% in
the cancer group. The locality in which the cohort was recruited
has the highest percentage of female gastric cancer patients in
the country (www.wcisu.nhs.uk). Also, the cancer group was
almost a decade younger then that expected nationally (www.
wcisu.nhs.uk), suggesting a possible local predisposition to this
form of cancer.
Of particular interest in this study was the amplification
of chromosome 4, which was detected with increasing frequency
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Figure 3 Chromosomal abnormalities separated by H. pylori status
showing significant differences in abundance. Chromosome 20 deletion and
4 gain are more prevalent in H. pylori-positive samples, whereas deletion of
8 is more prevalent in H. pylori-negative samples.
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Figure 4 Fluorescence in situ hybridisation data from AHH-1 cells
exposed to H2O2 for 30 min, showing similar chromosomal changes to
those detected in gastric tissue in vivo.
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as premalignant gastric tissue tended towards gastric adenocarci-
noma, suggesting that it may have an important link with the
initiation and development of gastric cancer. Chromosome 4
amplification has been recently shown to be a significant event in
the progression of Barrett’s oesophagus to adenocarcinoma,
especially in the early histological changes of this pathway (Croft
et al, 2002; Doak et al, 2003). The level of chromosome 4
amplification in the intestinal metaplasia samples studied here
(7%) was less than, but nonetheless comparable with, that seen in
the metaplasia patients with Barrett’s disease (12%) (Doak et al,
2003). Further work by our group has suggested the link between
the amplification of chromosome 4 and nuclear factor-kB (NF-kB)
(Jenkins et al, 2004). Nuclear factor-kB resides on chromosome 4
and NF-kB acts as an antiapoptotic factor, as well as influencing
the proinflammatory action of IL-8 (Rayet and Gelinas, 1999). The
increased copy number of NF-kB in cells with a chromosome 4
amplification may allow continued cell survival in the presence of
noxious gastric secretions. This aspect warrants further investiga-
tion. A recent report has illustrated gene expression changes
induced by coculture of AGS cells with H. pylori and attempted to
correlate these expression changes with known cytogenetic
anormalities in gastric cancer (Myllykangas et al, 2004). In the
paper by Myllykangas et al, six genes on chromosome 4 show
expression changes after coculture with H. pylori, with three genes
upregulated and three genes actually downregulated. Hence, this
does not fit well with our cytogenetic data which showed only
amplification of chromosome 4. However, comparing in vitro
models of gastric cancer and in vivo gastric tissue itself is
obviously not ideal.
Changes in chromosome 20 copy number have previously
been demonstrated in gastric cancer. In this study, amplification
of chromosome 20 was found frequently in premalignant tissue.
Panani et al (1995) have shown with CGH that amplification of
chromosome 20 can occur in gastric adenomas as well as gastric
carcinoma. In our study, abnormalities of chromosome 20
were usually found to be more frequent than other chromosomal
abnormalities, also having a higher prevalence in normal gastric
tissue. This could therefore be representative of general instability
of the tissue, and be a marker of aneuploidy, that is, chromosome
nondisjunction, due to increased cell proliferation. As for
candidate genes on chromosome 20, which could explain
its amplification, it is interesting to note that the Aurora kinase
A gene has been located to chromosome 20q13.2. Aurora kinase A
has been found previously to be overexpressed in tumours
and in cancer cell lines (Giet et al, 1999; Zou et al, 1999; Carmena
and Earnshaw, 2003) and is involved in the separation of
centrosomes as well as spindle assembly (Carmena and Earnshaw,
2003). Hence, amplification of chromosome 20 may reflect
abnormalities of this protein kinase, whose altered function may
have a role in the further development of aneuploidy, and hence
genetic instability in carcinogenesis. In the paper by Myllykangas,
eight genes on chromosome 20 show expression abnormalities, five
genes were upregulated and three genes downregulated. Indeed,
one particular locus on chromosome 20 (20pter-p11) showed the
largest number of upregulated genes. These upregulations in vitro
may be linked to the amplification of chromosome 20 in vivo, as
they would both cause increased activity of particular genes at
these loci.
P53 deletion was the other significant abnormality that emerged
during this study of gastric carcinogenesis, although p53 gain was
also evident in tissue of more advanced histological disease,
perhaps reflecting more general chromosome 17 aneuploidy. p53 is
involved in the control of cell cycle progression and apoptosis in
response to DNA damage, and hence loss of its function would lead
to genetic instability (Grady, 2001). This tumour suppressor gene
is the most frequently altered gene in human cancer (Levine et al,
1991) and loss of p53 is a frequent finding in gastric cancer (Grady,
2001). In this study, loss of p53 was shown to be a frequent
abnormality in premalignant tissue. Many studies have demon-
strated abnormalities of p53 in gastritis (Morgan et al, 2003), and
intestinal metaplasia (Uchino et al, 1993; Shiao et al, 1994) as well
as gastric cancer. In Myllykangas’s paper, 22 genes on chromo-
some 17 show expression changes, 15 of them upregulation. This
may reflect the late stage amplification of 17p that we detected here
and could involve the erbb-2 gene (17q12 –21). Three of the genes
in Myllykangas’s paper are present at 17p13 –11, a similar locus as
p53 and two of three of these genes show upregulation after
incubation with H. pylori. This disparity may be due to in vitro vs
in vivo factors.
Alterations in chromosome 8 copy number were also found in
premalignant and malignant gastric tissue, their prevalence
increasing with the histological progression. Other studies have
suggested that amplification of 8 is more frequent in advanced
cancers and therefore may be a late event (Wu et al, 2001). Both
deletions and amplifications were seen in this study in all tissue
types investigated, but amplification of 8 was seen in up to 20% of
cancers. Chromosome 8 houses an important oncogene, c-myc,
which acts as a proliferative transcription factor. Its overexpres-
sion has been observed in many tumour types, including gastric
cancers (Grady, 2001). There are some reports of abnormalities of
c-myc being present in the premalignant stages of gastric cancer.
Panani et al (1995) have shown gains of chromosome 8 in gastric
adenomas. One study reports frequencies of c-myc overexpression
in 36% of gastric cancers, and 15% of chronic gastritis. All these
abnormalities were also associated with abnormal p53 expression
(Nardone et al, 1999). The significant link between H. pylori-
negative patient tissue and chromosome 8 loss has an unknown
basis that might be worth pursuing. In Myllykangas’s paper, eight
genes on chromosome 8 show expression abnormalities, five
upregulation and three downregulation, reflecting our mixed
cytogenetic data.
Identification of H. pylori infection in this study was determined
by histology and PCR. Previous work by a number of groups has
supported the accuracy of PCR diagnosis of H. pylori infection
(Clayton et al, 1992; Lage et al, 1995; Ashton-Key et al, 1996). The
prevalence of H. pylori infection in this cohort of patients
undergoing upper GI endoscopy was 39%, and this is comparable
to the findings of a similar endoscopy-based study from the same
hospital in which multiple gastric biopsies were analysed for
H. pylori using PCR (Balaratnam et al, 2001). This infection rate is
also comparable to another European study looking at infection
rates in patients undergoing endoscopy that found 39% of gastric
biopsies had PCR evidence of H. pylori infection (Lage et al, 1995).
The further identification of the CagA strain by PCR was
undertaken, as it is known to be associated with greater disease
severity. The prevalence of the CagA strain of H. pylori in this
study was 43%, which is lower than in some of the other studies
reported but comparable to a local study in which only gastritis
patients were analysed, 44% of H. pylori infections in that study
were CagAþ (Morgan et al, 2003). Aneuploidy of chromosomes 4,
20 and 8 were more evident in H. pylori-positive tissue (Figure 3).
Abnormalities of p53 have already been associated with H. pylori-
positive infections (Murakami et al, 1999). In particular, in this
study, chromosome 4 amplification was significantly increased in
infected tissue. The link between H. pylori infection, an agent
known to be causally linked to gastric cancer, and the amplifica-
tion of chromosome 4 suggests the importance of H. pylori as an
initiating agent in gastric carcinogenesis, and the amplification of 4
as an early genetic event. Aneuploidy of chromosomes 4, 8 and 20
was also seen at a higher frequency in those gastric biopsies
infected with CagAþ H. pylori strains, but numbers here were too
small to make firm conclusions. This supports previous data that
has demonstrated that CagAþ strains were associated with greater
levels of DNA aneuploidy, and p53 and c-myc expression (Nardone
et al, 1999). Given the possible link between H. pylori strains and
chromosome 4 amplification, it is interesting to note that CagA
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infection has already been associated with greater IL-8 levels
(Crabtree et al, 1995). It is well known that NF-kB controls IL-8
gene expression and hence CagAþ strains may induce IL-8
upregulation via an NF-kB and chromosome 4-dependent
mechanism.
Helicobactor pylori is known to cause inflammation and the
release of ROS in gastric tissue (Bagchi et al, 1996; Farinati et al,
1998; Obst et al, 2000). Studies have shown that ROS and its
subsequent formation of oxidative DNA damage are important
factors in gastric cancer development (Correa and Shiao, 1994;
Stadtlander and Waterbor, 1999). Our in vitro study here has
demonstrated the types of aneuploidy induced by a model ROS,
H2O2, in a cell line routinely used in assessing chromosome
damage. Hydrogen peroxide was chosen as it has been found in
vivo, and therefore mimics the actual type of ROS released during
tissue inflammation (Fenech et al, 1999; Marnett, 2000). The types
of chromosomal abnormalities induced by this model ROS study
were similar to those found in gastric carcinogenesis, but most
comparable with gastritis. This is not surprising given that gastritis
is a highly inflammatory condition possessing high levels of ROS
(Marnett, 2000; Morgan et al, 2003).
Finally, it should be reiterated that even though a considerable
amount of FISH data has been accumulated, patient numbers in
this study were relatively small, especially when the cohort was
subdivided for analysis. As such, the observations made here
should be confirmed with larger studies targeted at the key
chromosomal abnormalities detected, which may represent useful
molecular markers for the future. Furthermore, it would be
important to repeat this study in histology sections to closely
match the cytogenetic information with the histology. Amplifica-
tion of chromosome 4 and its effect on NF-kB and IL-8, would be
important to follow up, as would the association with H. pylori
infection. Also, aneuploidy of chromosome 20, and the possible
relationship to Aurora kinase A and the development of further
aneuploidy, is of particular interest.
In conclusion, chromosomal instability has been demonstrated
in early gastric carcinogenesis and this may be the reason why
gastric cancer is such an aggressive disease.
REFERENCES
Acar H, Caliskan U, Demirel S, Largaespada DA (2001) Micronucleus
incidence and their chromosomal origin related to therapy in acute
lymphoblastic leukaemia (ALL) patients: detection by micronucleus and
FISH. Teratogen Carcin Mutagen 21(5): 341 – 347
Asaka M, Takeda H, Sugiyama T, Kato M (1997) What role does
Helicobacter pylori play in gastric cancer? Gastroenterolgy 113: S56 – S60
Ashton-Key M, Diss TC, Isaacson PG (1996) Detection of Helicobacter
pylori in gastric biopsy and resection specimens. J Clin Path 49: 107 – 111
Bagchi D, Bhattacharya G, Stohs SJ (1996) Production of reactive oxygen
species by gastric cells in association with Helicobacter pylori. Free Rad
Res 24: 439 – 450
Balaratnam N, Ishmail H, Jenkins G, Sallami BM, Griffiths P, Williams JG,
Parry JM (2001) Comparison of the geographical distribution and
prevalence of Helicobacter pylori vacA and cagA subtypes in a UK and
Saudi Arabian Population. Gut 49(Suppl 11): A34
Beckman KB, Ames BN (1997) Oxidative decay of DNA. J Biol Chem 272:
19633 – 19636
Beuzen F, Dubois S, Flejou J-F (2000) Chromosomal numerical aberrations
are frequent in oesophageal and gastric adenocarinoma: a study using
in-situ hybridisation. Histopathology 37: 241 – 249
Blaser MJ (1998) Helicobacter pylori and gastric diseases. BMJ 316:
1507 – 1510
Carmena M, Earnshaw WC (2003) The cellular geography of Aurora
kinases. Nat Rev 4: 842 – 854, (www.nature.com/reviews/molcellbio)
Chaleshtori M (1997) Application of medical genetics to the study of human
disease. University of Wales Swansea, PhD Thesis
Chan AO, Luk JMC, Hui W, Lam S (1999) Molecular biology of gastric
carcinoma: from laboratory to bedside. J Gastroenterol Hepatol 14:
1150 – 1160
Clayton CL, Kleanthous H, Coates PJ, Morgan DD, Tabaqchali S (1992)
Sensitive detection of Helicobacter pylori by using polymerase chain
reaction. J Clin Microbiol 30(1): 192 – 200
Correa P (1988) A human Model of gastric carcinogenesis. Cancer Res 48:
3554 – 3560
Correa P, Shiao Y (1994) Phenotypic and genotypic events in gastric
carcinogenesis. Cancer Research 54(Suppl): 1941 – 1943
Cover TL, Blaser MJ (1995) Helicobacter pylori: a bacterial cause of gastritis,
peptic ulcer disease and gastric cancer. Am Soc Microbiol News 61: 21 – 26
Crabtree JE, Cavacci A, Farmery SM, Xiang Z, Tompkins DS, Perry S,
Lindley IJD, Rappuoli R (1995) Helicobacter pylori induced interleukin 8
expression in gastric epithelial cells is associated with CagA positive
phenotype. J Clin Pathol 48(1): 41 – 45
Croft J, Parry EM, Jenkins GJS, Doak SH, Griffiths AP, Brown TH, Baxter
JN, Parry JM (2002) Analysis of the pre-malignant stages of Barretts
oesophagus through to adenocarcinoma by comparative genomic
hybridisation. Eur J Gastro Hepat 14: 1179 – 1186
Doak SH, Jenkins GJS, Parry EM, D’Souza FR, Griffiths AP, Toffazal N,
Shah V, Baxter JN, Parry JM (2003) Chromosome 4 hyperploidy
represents an early genetic aberration in pre-malignant Barrett’s
oesophagus. Gut 52: 623 – 628
D’souza FR, Jenkins GJ, Parry EM, Baxter JN, Parry JM (2003) Bile acids: do
they play a role in Barretts oesophagus. Gut 52A47
Duthie SJ, Collins AR, Duthie GG, Dodson VL (1997) Quectrin and
myricetin protect against hydrogen peroxide induced DNA damage
(strand breaks and oxidised pyrimidines) in human lymphocytes. Mutat
Res 393: 223 – 231
Faraji E, Frank B (2002) Mutifocal atrophic gastritis and gastric carcinoma.
Gastroenterol Clin N Am 31: 499 – 516
Farinati F, Cardin R, Degan P, Rugge M, Mario FD, Bonvicini P, Narcarato
R (1998) Oxidative DNA damage accumulation in gastric carcinogenesis.
Gut 42: 351 – 354
Fenech M, Crott J, Turner J, Brown S (1999) Necrosis, apoptosis, cytostasis
and DNA damage in human lymphocytes measured simultaneously
within the cytokinesis-block micronucleus assay: description of the
method and results for hydrogen peroxide. Mutagenesis 14(6): 605 – 612
Fenech M, Morley AA (1985) Measurment of micronuclei in lymphocytes.
Mutat Res 147: 29 – 36
Fiocca R, Luinetti O, Villani L, Chiaravalli AM, Capella C, Solcia E (1994)
Epithelial cytotoxicity, immine responses and inflammatory components
of Helicobacter pylori gastritis. Scand J Gastro 29(Suppl 205): 11 – 21
Frias S, Van Hummelen P, Meistrich ML, Lowe XR, Hagemeister FB, Shelby
MD, Bishop JB, Wyrobek AJ (2003) Novp chemotherapy for Hodgkin’s
disease transiently induces sperm aneuploidies associated with mahor
clinical aneuploidy syndromes involving chromosomes x, y, 18 AND 21.
Cancer Res 63(1): 44 – 51
Giet R, Uzbekhov R, Cubizolles F, Le Guellec K, Prigent C (1999) The
Xenopus laevis aurora related protein kinase pEq2 associates with and
phosphorylates the Kinesin related protein X1Eq5. J Biol Chem 274:
15005 – 15013
Grady WM (2001) Genetics of Gastric Cancer. Molecular Genetics of Cancer,
2nd ed. Oxford: BIOS Scientific Publishes Ltd
Graham DY (2000) Helicobacter pylori infection is the primary cause of
gastric cancer. J Gastroenterol 35(Suppl XII): 90 – 97
Hussain SP, Harris CC (1998) Molecular epidemiology of human cancer:
contribution of mutation spectra studies of tumor suppressor genes.
Cancer Res 58: 4023 – 4037
International Agency for Research on Cancer (IARC) (1994) Schistosomes,
liver flukes and Helicobacter pylori. Monogr Eval Carcinog Risks Hum 61:
177 – 220
Ishmail H (2004) Molecular analysis of Helicobacter pylori subtypes PhD
Thesis, University of Wales, Swansea, 2004.
Jenkins GJS, Harries K, Doak SH, Wilmes A, Griffiths AP, Baxter JN, Parry
JM (2004) The bile deoxycholic acid (DCA) at neutral Ph, activates
NFKbeta and induces IL-8 expression in oesophageal cells in vitro:
implications for acid suppression and correlation with chromosome 4
amplification in Barrett’s tissues. Carcinogenesis 25(3): 317 – 323
FISH analysis of chromosomal aberrations in gastric tissue
L Williams et al
1765
British Journal of Cancer (2005) 92(9), 1759 – 1766& 2005 Cancer Research UK
M
o
le
c
u
la
r
D
ia
g
n
o
st
ic
s
Jenkins GJS, Morgan C, Baxter JN, Parry EM, Parry JM (2001) The detection
of mutations induced in vitro in the human p53 gene by hydrogen
peroxide with the restriction site mutation (RSM) assay. Mutat Res 498:
135 – 144
Kamiguchi Y, Tateno H (2002) Radiation and chemical induced chromo-
some aberrations in human spermatozoa. Mutat Res 504(1 – 2): 183 – 191
Keighley MRB (2003) Gastrointestinal cancers in Europe. Aliment
Pharmacol Ther 18(Suppl 3): 7 – 30
Kitayama Y, Igarashi H, Sugimura H (2000) Different vulnerability among
chromosomes to numerical instability in gastric carcinogenesis: stage-
dependent analysis by FISH with the use of microwave irradiation. Clin
Cancer Res 6(8): 3139 – 3146
Kokkola A, Monni O, Puolakkainen P, Nordling S, Haapianen R, Kivilaakso
E, Knuutila S (1998) Presence of high level DNA copy number gains in
gastric cancer and severely dysplastic adenomas but not in moderately
dysplastic adenomas. Cancer Genet Cytogenet 107: 32 – 36
Koo SH, Kwon KC, Shin SY, Jeon YM, Park JW, Kim SH, Noh SM (2000)
Genetic alterations of gastric cancer: comparative genomic hybridisation
and fluoresence in situ hybridisation studies. Cancer Genet Cytogenet
117: 97 – 103
Lage AP, Godfroid E, Fauconnier A, Burette A, Butlzer J-P, Bollen A,
Glupczynski Y (1995) Diagnosis of Helicobacter pylori infection by PCR:
comparison with other invasive techniques and detection of cagA gene in
gastric biopsy specimens. J Clin Microbiol 33(10): 2752 – 2756
Lengauer C, Kinzler KW, Vogelstein B (1997) Genetic instability in
colorectal cancers. Nature 386: 623 – 627
Levine AJ, Momand J, Finlay CA (1991) The p53 tumour suppressor gene.
Nature 351: 453 – 456
Lindforss U, Fredholm H, Papadogiannakis N, Gad A, Zetterquist H,
Olivecrona H (2000) Allelic loss is heterogenous throughout the tumour
in colorectal carcinoma. Cancer 88(12): 2661 – 2667
Marnett LJ (2000) Oxyradicals and DNA damage. Carcinogenesis 21(3):
361 – 370
Matturri L, Biondo B, Cazzullo A, Colombo B, Giordano F, Guarino M,
Pallotti F, Turconi P, Lavezzi AM (1998) Prognostic significance of
different biological markers (DNA index, PCNA index, apoptosis, p53,
karyotype) in 126 adenocarcinoma gastric biopsies. Anticancer Res 18:
2819 – 2825
Morgan C, Jenkins GJS, Ashton T, Griffiths AP, Baxter JN, Parry EM, Parry
JM (2003) The detection of p53 mutations in pre-cancerous gastric tissue
using the restriction site mutation (RSM) assay. Br J Cancer 89: 1314 –
1319
Murakami K, Fujioka T, Okimoto Y, Mitsuish T, Oda A, Nishizono A, Nasu
M (1999) Analysis of p53 muatations in Helicobatcer pylori-asociated
gastritis mucosa in endoscopic biopsy specimens. Scand J Gastroenterol
5: 474 – 477
Myllykangas S, Monni O, Nagy B, Rautelin H, Knuutila S (2004)
Helicobacter pylori infection activates fos and stress response genes
and alters expression of genes in gastric cancer specific loci. Genes
Chromosomes and Cancer 40: 334 – 341
Nardone G, Staibano S, Rocco E, Mezzo E, D’Armiento FP, Insabato L,
Coppola A, Salvatore G, Lucariello A, Figura N, De Rosa G, Budillon G
(1999) Effect of Helicobacter pylori infection and its eradication on cell
proliferation, DNA status, and oncogene expression in patients with
chronic gastritis. Gut 44: 789 – 799
Obst B, Wagner S, Sewing KF, Beil W (2000) Helicobacter pylori causes
DNA damage in gastric epithelial cells. Carcinogenesis 21(6): 1111 – 1115
O’Connor H, Sebastian S (2003) The burden of Helicobacter pylori infection
in Europe. Aliment Pharmacol ther 18(Suppl 3): 38 – 44
Okada K, Sugihara H, Bamba M, Bamba T, Hattori T (2000) Sequential
numerical changes of chromosomal 7 and 18 in diffuse-type stomach
cancer cell lines: combined comparative genomic hybridisation,
fluoresence in situ hybridisation, and ploidy analyses. Cancer Genet
Cytogenet 118: 99 – 107
Owonikoko T, Rees M, Gaggert H, Sarbia M (2002) Intratumoral genetic
heterogeneity in Barrett adenocarcinoma. Am J Clin Pathol 117(14):
558 – 566
Panani AD, Ferti A, Malliaros S, Raptis S (1995) Cytogenetic study of 11
gastric adenocarcinomas. Cancer Genet Cytogenet 81: 169 – 172
Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The
global picture. Eur J Cancer 37(Suppl 8): S4 – S66
Perwez Hussain SP, Aguilar F, Amstad P, Cerutti P (1994) Oxyradical
induced mutagenesis of hotspot codons 248 and 249 of the human gene
p53. Oncogene 9: 2277 – 2281
Rayet B, Gelinas C (1999) Aberrant rel/NFkb genes and activity in human
cancer. Oncogene 18: 6938 – 6947
Rueff J, Bras A, Cristovao L, Mexia J, Sa Da Costa M, Pires V (1993) DNA
strand breaks and chromosomal aberrations induced by H202 and
60Co
gamma-radiation. Mutat Res 289(2): 197 – 204
Scates DK, Spigelman AD, Phillips RKS, Venitt S (1996) Differences in the
levels and pattern of DNA adduct labelling in human cell lines MCL5 and
CCRF. Proficient in carcinogen metabolism, treated in vitro with bile
from familial adenomatous polyposis patients and from unaffected
controls. Carcinogenesis 17: 707 – 713
Scates DK, Venitt S, Phillips RKS, Spigelman AD (1995) High pH
reduces DNA damage caused by bile from patients with familial
adenomatous polyposis-antacids mat attenuate duodenal polyposis.
Gut 36: 918 – 921
Shiao YP, Rugge M, Correa P, Lehmann HP, Scheer WD (1994) p53
alterations in gastric precancerous lesions. Am J Pathol 144: 511 – 517
Silva LM, Takahashi CS, Carrara HHA (2002) Study of chromosome
damage in patients with breast cancer treated by two antineoplastic
treatments. Tereatogen Carcin Mutagen 22(4): 257 – 269
Sipponen P, Hyvarnin H, Seppala K, Blaser MJ (1998) Review article:
pathogenesis of the transformation from gastritis to malignancy. Aliment
Pharrmacol Ther 12(Suppl 1): 61 – 71
Stadtlander CTK, Waterbor JW (1999) Molecular epidemiology, patho-
genesis and prevention of gastric cancer. Cancer Res 54: 95 – 102
Tamura G, Kihana T, Nomura K, Terada M, Sugimura T, Hirohashi S
(1991) Detection of frequent p53 gene mutations in primary gastric
cancer by cell sorting and polymerase chain reaction single stranded
conformation polymorphism analysis. Cancer Res 51: 3056 – 3058
Uchino S, Noguchi M, Ochiai M, Saito T, Kobayashi M, Hirohashi S (1993)
p53 mutation in gastric cancer: a genetic model for carcinogenesis is
common to gastric and colorectal cancer. Int J Cancer 54: 759 – 764
Umegaki K, Fenech M (2000) Cytokinesis block micronucleus assay in
WIL-NS cells: a sensitive system to detect chromosomal damage induced
by reactive oxygen species and activated human neutrophils. Muta-
genesis 15(3): 261 – 269
Vogelstein B, Kinzer PW (1992) P53 function and dysfunction. Cell 70:
523 – 526
Wu M, Chang M, Huang S, Tseng C, Sheu J, Lin Y, Shun C, Lin M, Lin J
(2001) Correlation of the histologic subtypes and the replication error
phenotype with comparative genomic hybridisation in gastric cancer.
Gene chromosomes and cancer 30(1): 80 – 86
You WC, Zhang L, Gail MH, Chang YS, Liu WD, Ma JL, Li JY, Jin ML, Hu
YR, Yang CS, Blaser MJ, Correa P, Blot WJ, Fraumeni JF, Xu GW (2000)
Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin
C and other risk factors. J Natl Cancer Inst 92(19): 1607 – 1612
Zou H, McGarry TJ, Bernal T, Kirschner MW (1999) Identification of a
vertebrate sister chromatid separation inhibitor involved in transforma-
tion and tumourigenesis. Science 285: 418 – 421
FISH analysis of chromosomal aberrations in gastric tissue
L Williams et al
1766
British Journal of Cancer (2005) 92(9), 1759 – 1766 & 2005 Cancer Research UK
M
o
le
c
u
la
r
D
ia
g
n
o
stic
s
